Psychological distress and resilience in patients with gastroenteropancreatic neuroendocrine tumor

por Song, Lili, Cao, Yanshuo, Li, Jie, Lu, Ming, Tang, Lili
Publicado 2022

Dynamic monitoring of circulating tumour cells to evaluate therapeutic efficacy in advanced gastric cancer

por Li, Yilin, Gong, Jifang, Zhang, Qiyue, Lu, Zhihao, Gao, Jing, Li, Yanyan, Cao, Yanshuo, Shen, Lin
Publicado 2016

Favorable response to immunotherapy in a pancreatic neuroendocrine tumor with temozolomide‐induced high tumor mutational burden

por Cao, Yanshuo, Ma, Yutong, Yu, Jiangyuan, Sun, Yu, Sun, Tingting, Shao, Yang, Li, Jie, Shen, Lin, Lu, Ming
Publicado 2020

Aneuploidy of chromosome 8 in circulating tumor cells correlates with prognosis in patients with advanced gastric cancer

por Li, Yilin, Zhang, Xiaotian, Gong, Jifang, Zhang, Qiyue, Gao, Jing, Cao, Yanshuo, Wang, Daisy Dandan, Lin, Peter Ping, Shen, Lin
Publicado 2016

Clinical significance of phenotyping and karyotyping of circulating tumor cells in patients with advanced gastric cancer

por Li, Yilin, Zhang, Xiaotian, Ge, Sai, Gao, Jing, Gong, Jifang, Lu, Ming, Zhang, Qiyue, Cao, Yanshuo, Wang, Daisy Dandan, Lin, Peter Ping, Shen, Lin
Publicado 2014

Serum Biomarker Status with a Distinctive Pattern in Prognosis of Gastroenteropancreatic Neuroendocrine Carcinoma

por Zhang, Jianwei, Cao, Yanshuo, Zhang, Panpan, Zhang, Xiaotian, Li, Jian, Zhou, Jun, Wang, Xicheng, Peng, Zhi, Sun, Yu, Li, Jie, Shen, Lin, Lu, Ming
Publicado 2022

Surufatinib plus toripalimab in patients with advanced solid tumors: a single-arm, open-label, phase 1 trial

por Cao, Yanshuo, Lu, Ming, Sun, Yu, Gong, Jifang, Li, Jie, Lu, Zhihao, Li, Jian, Zhang, Xiaotian, Li, Yan, Peng, Zhi, Zhou, Jun, Wang, Xicheng, Shen, Lin
Publicado 2022

Phase Ib study of anlotinib combined with TQB2450 in pretreated advanced biliary tract cancer and biomarker analysis

por Zhou, Jun, Sun, Yongkun, Zhang, Wen, Yuan, Jiajia, Peng, Zhi, Wang, Wei, Gong, Jifang, Yang, Lin, Cao, Yanshuo, Zhao, Hong, Chen, Chao, Wang, Weifeng, Shen, Lin, Zhou, Aiping
Publicado 2023

Pyrotinib alone or in combination with docetaxel in refractory HER2‐positive gastric cancer: A dose‐escalation phase I study

por Liu, Dan, Kou, Furong, Gong, Jifang, Wang, Zhiqiang, Zhang, Xiaotian, Li, Jian, Li, Yan, Li, Jie, Zhou, Jun, Lu, Ming, Wang, Xicheng, Lu, Zhihao, Cao, Yanshuo, Zou, Jianjun, Zhu, Xiaoyu, Xu, Ruihua, Shen, Lin
Publicado 2023

Early Interdisciplinary Supportive Care in Patients With Previously Untreated Metastatic Esophagogastric Cancer: A Phase III Randomized Controlled Trial

por Lu, Zhihao, Fang, Yu, Liu, Chang, Zhang, Xiaotian, Xin, Xiaowei, He, Yi, Cao, Yanshuo, Jiao, Xi, Sun, Tianqi, Pang, Ying, Wang, Yanli, Zhou, Jun, Qi, Changsong, Gong, Jifang, Wang, Xicheng, Li, Jian, Tang, Lili, Shen, Lin
Publicado 2021

A Phase Ib Study of the Simmitecan Single Agent and in Combination With 5-Fluorouracil/Leucovorin or Thalidomide in Patients With Advanced Solid Tumor

por Zhang, Qi, Deng, Ting, Yang, Fen, Guo, Weijian, Liu, Dan, Yuan, Jiajia, Qi, Changsong, Cao, Yanshuo, Yu, Qiuqiong, Cai, Huiming, Peng, Zhi, Wang, Xicheng, Zhou, Jun, Lu, Ming, Gong, Jifang, Li, Jian, Ba, Yi, Shen, Lin
Publicado 2022

Phase I study of the recombinant humanized anti-HER2 monoclonal antibody–MMAE conjugate RC48-ADC in patients with HER2-positive advanced solid tumors

por Xu, Yingying, Wang, Yakun, Gong, Jifang, Zhang, Xiaotian, Peng, Zhi, Sheng, Xinan, Mao, Chenyu, Fan, Qingxia, Bai, Yuxian, Ba, Yi, Jiang, Da, Yang, Fen, Qi, Changsong, Li, Jian, Wang, Xicheng, Zhou, Jun, Lu, Ming, Cao, Yanshuo, Yuan, Jiajia, Liu, Dan, Wang, Zhenghang, Fang, Jianmin, Shen, Lin
Publicado 2021

Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial interim results

por Qi, Changsong, Gong, Jifang, Li, Jian, Liu, Dan, Qin, Yanru, Ge, Sai, Zhang, Miao, Peng, Zhi, Zhou, Jun, Cao, Yanshuo, Zhang, Xiaotian, Lu, Zhihao, Lu, Ming, Yuan, Jiajia, Wang, Zhenghang, Wang, Yakun, Peng, Xiaohui, Gao, Huiping, Liu, Zhen, Wang, Huamao, Yuan, Daijing, Xiao, Jun, Ma, Hong, Wang, Wei, Li, Zonghai, Shen, Lin
Publicado 2022